Latest Revenue Streaming News

Algorae Pharmaceuticals has clinched a multi-year public hospital supply contract with NSW Health, marking a significant commercial milestone. The rollout is set to begin in the fourth quarter of 2026, underpinning the company's growth ambitions in the Australian healthcare market.

St George Mining delivers a new benchmark intercept of nearly 200 metres of continuous high-grade rare earths and niobium from surface at its Araxá project, reinforcing its scale and open-pit potential.

Biome Australia has posted a 30% increase in FY26 sales revenue to $23.9 million, driven by strong domestic demand and strategic moves into onshore manufacturing and international markets.

Monadelphous Group has landed over $200 million in new contracts spanning wind turbine installation, maintenance, and construction services across Australia and Papua New Guinea.

Burger Fuel Group posted a 92% surge in net profit to NZ$1.97 million for FY26, driven by steady system sales growth, a one-off store sale gain, and reduced legal expenses, while geopolitical instability in the Middle East weighs on international sales.

BSA Limited has locked in its role as Foxtel’s exclusive national supplier for at least three more years, extending a partnership that began in 1998. The contract now runs until October 2029, with two additional one-year options available.

Boom Logistics has locked in a five-year extension with BHP at Olympic Dam, underpinning $40 million in annual revenue and reinforcing its long-term partnership strategy.

Booster Investment Scheme 2's Private Land and Property Fund swung back to profit with NZD 1.3 million after tax for the year ended March 2026, despite net asset value slipping due to unit redemptions. The Fund’s investment portfolio remains concentrated in unlisted New Zealand agricultural and property assets, while its Manager faces unrelated FMA proceedings.

New Talisman Gold Mines commissioned its processing plant and secured commercial offtakes while reporting a $2.26 million net loss in FY26. The company is refocusing on geological modelling and targeted drilling to boost resource confidence and production.

Neuren’s partner Acadia secures positive CHMP opinion for DAYBU® in Rett syndrome, paving the way for first EU treatment approval and triggering significant milestone payments for Neuren.

TruScreen Group posted a NZ$2.25 million loss for FY2026, with its auditor highlighting material uncertainty over the company’s ability to continue without further funding. Revenue rose to NZ$2.4 million amid geographic expansion, but cash burn and accumulated losses remain significant.

Radius Residential Care boosted its profit before tax by 37% to $14.3 million in FY26, driven by strong operational performance and strategic acquisitions. The group now operates over 2,000 beds across 25 care homes and four villages, with a focus on high-acuity care and diversified services including home support and catering.